Food and Drug Administration (FDA) approval of TAVNEOS in October 2021.

Dasatinib-induced ERK activation was completely abolished by exposure to the FDA-approved MEK inhibitor The results provide rationale for considering a combination(s) of FDA-approved SFK (dasatinib) and MEK

January 2022 "After securing FDA approval for Wegovy last year, Novo Nordisk is strengthening its position

September 2022 "Background G protein-coupled receptor (GPCR) is the most targeted protein family by the FDA-approved

importance in a wide range of physiological functions and in a large number of Food and Drug Administration (FDA

Food and Drug Administration (FDA) that the study may proceed.

2022 "GPCRs modulate a plethora of physiological processes and mediate the effects of one-third of FDA-approved

novel IV analgesic that has been approved in the United States by the Food and Drug Administration (FDA

In contrast, blocking AVPR2 with a selective FDA-approved antagonist, tolvaptan, reduced cell growth.

While no drugs targeting LPARs have been approved by the FDA thus far, at least three antagonists have

Phase 1 Clinical Studies AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion FDA

structures of human GPR34 enable the identification of selective antagonists Industry News Inside the FDA's

Research Collaboratives Program AIRSUPRA® (albuterol/budesonide) now available as the first and only FDA-approved

The anti-CCR4 antibody mogamulizumab has also been approved in Japan and by the FDA for the treatment

FDA Accepts New Drug Applications and Grants Priority Review for Crinecerfont for Pediatric and Adult

Class A GPCR GPR3 Antimalarial and Plasmodium falciparum serpentine receptor 12 targeting effect of FDA

Sciences Startups to Watch in 2023 by BioSpace Sosei Heptares Notes its Partner Tempero Bio has Received FDA

Fungi Hijack Hosts’ Brains GPCR Therapeutics, Inc. has received Orphan Drug Designation (ODD) from the FDA